ArticleDiabetes therapy : research, treatment and education of diabetes and related disorders2015

Is There Evidence of Any Safety Differences Among DPP-4 Inhibitors in the Treatment of People with Type 2 Diabetes Mellitus and Reduced GFR Due to Chronic Kidney Disease?

Marc Evans et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.